RAPT Competitors & Alternatives
Compare RAPT Therapeutics Inc with similar stocks in the same industry
Biotechnology
RAPT
Main Stock$58.02
Tradestie Score
53
Market Cap
$450.49M
Revenue Growth
-1.0%
Analyst Upside
0.0%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MPLT
MPLT
|
$36.57
|
$1.78B | - | 63 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$6.52
|
$1.78B | - | 59 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$23.64
|
$1.78B | - | 63 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$18.99
|
$1.74B | - | 61 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$38.53
|
$1.68B | - | 62 | Compare |
|
MNKD
Mannkind Corporation
|
$4.04
|
$1.65B | - | 51 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$41.27
|
$1.63B | - | 64 | Compare |
|
BHVN
Biohaven Ltd.
|
$15.17
|
$1.57B | - | 59 | Compare |
|
VCEL
Vericel Corporation
|
$47.49
|
$1.56B | 109.3 | 61 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$98.64
|
$1.55B | - | 59 | Compare |
More RAPT Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry